ThermoGenesis Holdings, Inc.
- Jurisdiction
United States - LEI
54930046CTH3DLQ1AR47 - ISIN
US88362L2097 (THMO )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
2
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. Read full profile
Fundamentals
- Net revenue
€8.20M - Gross margin
21.1% - EBIT
-€6.93M - EBIT margin
-84.5% - Net income
-€12.58M - Net margin
-153.4%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: November 13, 2023 (Q3 2023)